Intermittent claudication: next-generation therapy

Given that existing therapies for intermittent claudication are not appropriate for all patients, researchers are working to develop new therapies focused on improving patients’ ability to compensate for a vascular occlusion by expanding collateral artery pathways. By Steven J. Miller, PhD; A

Given that existing therapies for intermittent claudication are not appropriate for all patients, researchers are working to develop new therapies focused on improving patients’ ability to compensate for a vascular occlusion by expanding collateral artery pathways. By Steven J. Miller, PhD; A

Read the article:
Intermittent claudication: next-generation therapy